抗球虫药物市场－全球产业规模、份额、趋势、机会及预测（依药物类别、药物作用机制、动物类型、配销通路、地区及竞争格局划分，2020-2030 年预测）

2024年全球抗球虫药市场规模为14.1亿美元，预计2030年将以3.96%的复合年增长率成长至17.8亿美元。抗球虫药是用于预防和治疗球虫病的药物，球虫病是一种主要影响牲畜（尤其是家禽）肠道的寄生虫病，由艾美球虫属（Eimeria）原生动物引起。全球对动物性蛋白质的需求不断增长，导致集约化养殖方式的普及，进而增加了球虫病的发生率，这从根本上推动了该市场的成长。

主要市场驱动因素

全球抗球虫药物市场正经历显着扩张，这主要受畜禽球虫病流行率不断攀升以及全球对动物性蛋白质需求日益增长的推动。由艾美球虫引起的球虫病传播广泛，因此，必须持续采取有效的药物干预措施来维护动物的健康和生产力。

主要市场挑战

抗药性球虫菌株的不断出现严重阻碍了全球抗球虫药物市场的成长。这一普遍存在的问题直接削弱了现有药物治疗的疗效，因此需要不断创新，并加强研发投入，以开发新型化合物和治疗策略。

主要市场趋势

转向天然益生菌和益生元等天然成分的球虫病防治方法代表着一个重要的趋势，其驱动因素包括消费者对无残留动物产品的需求不断增长，以及行业应对抗药性挑战的迫切需求。生产者越来越多地在饲料中添加益生菌和益生元等添加剂，以促进肠道健康，增强动物的天然免疫力。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球抗球虫药物市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依药物类别（离子载体、抗生素、磺胺类药物、化学衍生物、其他药物类别）
  • 依药物作用机转（抑球虫药、杀球虫药）
  • 依动物类型（生产动物、伴侣动物）
  • 按配销通路（兽医院、零售药局、其他分销管道）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美抗球虫药物市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲抗球虫药物市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区抗球虫药市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲抗球虫药物市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲抗球虫药物市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球抗球虫药物市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Vetoquinol SA
• Zoetis Philippines Inc.
• Phibro Animal Health Corporation
• Huvepharma, Inc.
• Elanco US Inc.
• Biochem Pharmaceutical Industries Ltd
• Ceva Sante Animale SA
• Impextraco NV
• Boehringer Ingelheim International GmbH
• Merck & Co., Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Anticoccidial Drugs Market, valued at USD 1.41 Billion in 2024, is projected to experience a CAGR of 3.96% to reach USD 1.78 Billion by 2030. Anticoccidial drugs are pharmaceutical agents developed to prevent and treat coccidiosis, a parasitic disease primarily impacting the intestinal tracts of livestock, particularly poultry, caused by protozoa of the genus *Eimeria*. The market's growth is fundamentally supported by the escalating global demand for animal protein, leading to intensive farming practices that increase coccidiosis incidence.

Key Market Drivers

The global anticoccidial drugs market experiences significant expansion driven by the escalating prevalence of coccidiosis in livestock and poultry, coupled with a growing global demand for animal protein. The widespread nature of coccidiosis, caused by *Eimeria* protozoa, consistently necessitates effective pharmaceutical interventions to maintain animal health and productivity.

Key Market Challenges

The continuous development of drug-resistant coccidia strains presents a significant impediment to the growth of the Global Anticoccidial Drugs Market. This pervasive issue directly undermines the effectiveness of existing pharmaceutical treatments, necessitating constant innovation and substantial investment in research and development for novel compounds and treatment strategies. As existing drugs become less potent against evolved parasite strains, their market value and utility diminish, compelling manufacturers to shoulder considerable costs for developing new solutions. This prolonged and costly development cycle for effective new drugs, coupled with the shortened effective lifespan of current products due to resistance, directly stifles overall market expansion.

Key Market Trends

The shift towards natural and probiotic-based coccidiosis management represents a significant trend, driven by increasing consumer demand for residue-free animal products and the industry's need to address drug resistance challenges. Producers are increasingly incorporating feed additives, such as probiotics and prebiotics, to foster robust gut health and enhance the animals' natural immunity. This approach reduces reliance on conventional anticoccidial drugs.

Key Market Players

• Vetoquinol SA
• Zoetis Philippines Inc.
• Phibro Animal Health Corporation
• Huvepharma, Inc.
• Elanco US Inc.
• Biochem Pharmaceutical Industries Ltd
• Ceva Sante Animale SA
• Impextraco NV
• Boehringer Ingelheim International GmbH
• Merck & Co., Inc.

Report Scope:

In this report, the Global Anticoccidial Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anticoccidial Drugs Market, By Drug Class:

• Ionophore
• Antibiotic
• Sulphonamides
• Chemical Derivative
• Other Drug Classes

Anticoccidial Drugs Market, By Drug Action:

• Coccidiostatic
• Coccidiocidal

Anticoccidial Drugs Market, By Animal Type:

• Production Animals
• Companion Animals

Anticoccidial Drugs Market, By Distribution Channel:

• Veterinary Hospitals
• Retail Pharmacy
• Other Distribution Channels

Anticoccidial Drugs Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Anticoccidial Drugs Market.

Available Customizations:

Global Anticoccidial Drugs Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Anticoccidial Drugs Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Drug Class (Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes)
  • 5.2.2. By Drug Action (Coccidiostatic, Coccidiocidal)
  • 5.2.3. By Animal Type (Production Animals, Companion Animals)
  • 5.2.4. By Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Anticoccidial Drugs Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Drug Class
  • 6.2.2. By Drug Action
  • 6.2.3. By Animal Type
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Anticoccidial Drugs Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Drug Class
      • 6.3.1.2.2. By Drug Action
      • 6.3.1.2.3. By Animal Type
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Canada Anticoccidial Drugs Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Drug Class
      • 6.3.2.2.2. By Drug Action
      • 6.3.2.2.3. By Animal Type
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Mexico Anticoccidial Drugs Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Drug Class
      • 6.3.3.2.2. By Drug Action
      • 6.3.3.2.3. By Animal Type
      • 6.3.3.2.4. By Distribution Channel

7. Europe Anticoccidial Drugs Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Drug Class
  • 7.2.2. By Drug Action
  • 7.2.3. By Animal Type
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Anticoccidial Drugs Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Drug Class
      • 7.3.1.2.2. By Drug Action
      • 7.3.1.2.3. By Animal Type
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. France Anticoccidial Drugs Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Drug Class
      • 7.3.2.2.2. By Drug Action
      • 7.3.2.2.3. By Animal Type
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Anticoccidial Drugs Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Drug Class
      • 7.3.3.2.2. By Drug Action
      • 7.3.3.2.3. By Animal Type
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Anticoccidial Drugs Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Drug Class
      • 7.3.4.2.2. By Drug Action
      • 7.3.4.2.3. By Animal Type
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Anticoccidial Drugs Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Drug Class
      • 7.3.5.2.2. By Drug Action
      • 7.3.5.2.3. By Animal Type
      • 7.3.5.2.4. By Distribution Channel

8. Asia Pacific Anticoccidial Drugs Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Drug Class
  • 8.2.2. By Drug Action
  • 8.2.3. By Animal Type
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Anticoccidial Drugs Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Drug Class
      • 8.3.1.2.2. By Drug Action
      • 8.3.1.2.3. By Animal Type
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Anticoccidial Drugs Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Drug Class
      • 8.3.2.2.2. By Drug Action
      • 8.3.2.2.3. By Animal Type
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. Japan Anticoccidial Drugs Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Drug Class
      • 8.3.3.2.2. By Drug Action
      • 8.3.3.2.3. By Animal Type
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. South Korea Anticoccidial Drugs Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Drug Class
      • 8.3.4.2.2. By Drug Action
      • 8.3.4.2.3. By Animal Type
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Anticoccidial Drugs Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Drug Class
      • 8.3.5.2.2. By Drug Action
      • 8.3.5.2.3. By Animal Type
      • 8.3.5.2.4. By Distribution Channel

9. Middle East & Africa Anticoccidial Drugs Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Drug Class
  • 9.2.2. By Drug Action
  • 9.2.3. By Animal Type
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Anticoccidial Drugs Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Drug Class
      • 9.3.1.2.2. By Drug Action
      • 9.3.1.2.3. By Animal Type
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. UAE Anticoccidial Drugs Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Drug Class
      • 9.3.2.2.2. By Drug Action
      • 9.3.2.2.3. By Animal Type
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. South Africa Anticoccidial Drugs Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Drug Class
      • 9.3.3.2.2. By Drug Action
      • 9.3.3.2.3. By Animal Type
      • 9.3.3.2.4. By Distribution Channel

10. South America Anticoccidial Drugs Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Drug Class
  • 10.2.2. By Drug Action
  • 10.2.3. By Animal Type
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Anticoccidial Drugs Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Drug Class
      • 10.3.1.2.2. By Drug Action
      • 10.3.1.2.3. By Animal Type
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Colombia Anticoccidial Drugs Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Drug Class
      • 10.3.2.2.2. By Drug Action
      • 10.3.2.2.3. By Animal Type
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. Argentina Anticoccidial Drugs Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Drug Class
      • 10.3.3.2.2. By Drug Action
      • 10.3.3.2.3. By Animal Type
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Anticoccidial Drugs Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Vetoquinol SA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Zoetis Philippines Inc.
• 15.3. Phibro Animal Health Corporation
• 15.4. Huvepharma, Inc.
• 15.5. Elanco US Inc.
• 15.6. Biochem Pharmaceutical Industries Ltd
• 15.7. Ceva Sante Animale SA
• 15.8. Impextraco NV
• 15.9. Boehringer Ingelheim International GmbH
• 15.10. Merck & Co., Inc.

16. Strategic Recommendations

17. About Us & Disclaimer